|
|
||||||||
Departments of 1Molecular and Integrative Physiology, 2Biomedical Engineering, and 3Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, Michigan
Submitted 2 February 2006 ; accepted in final form 10 May 2006
Myostatin is a negative regulator of muscle mass. The impact of myostatin deficiency on the contractile properties of healthy muscles has not been determined. We hypothesized that myostatin deficiency would increase the maximum tetanic force (Po), but decrease the specific Po (sPo) of muscles and increase the susceptibility to contraction-induced injury. The in vitro contractile properties of extensor digitorum longus (EDL) and soleus muscles from wild-type (MSTN+/+), heterozygous-null (MSTN+/), and homozygous-null (MSTN/) adult male mice were determined. For EDL muscles, the Po of both MSTN+/ and MSTN/ mice were greater than the Po of MSTN+/+ mice. For soleus muscles, the Po of MSTN/ mice was greater than that of MSTN+/+ mice. The sPo of EDL muscles of MSTN/ mice was less than that of MSTN+/+ mice. For soleus muscles, however, no difference in sPo was observed. Following two lengthening contractions, EDL muscles from MSTN/ mice had a greater force deficit than that of MSTN+/+ or MSTN+/ mice, whereas no differences were observed for the force deficits of soleus muscles. Myostatin-deficient EDL muscles had less hydroxyproline, and myostatin directly increased type I collagen mRNA expression and protein content. The difference in the response of EDL and soleus muscles to myostatin may arise from differences in the levels of a myostatin receptor, activin type IIB. Compared with the soleus, the amount of activin type IIB receptor was approximately twofold greater in EDL muscles. The results support a significant role for myostatin not only in the mass of muscles but also in the contractility and the composition of the extracellular matrix of muscles.
GDF-8; muscle morphology; muscle injury
This article has been cited by other articles:
![]() |
B. Blaauw, C. Mammucari, L. Toniolo, L. Agatea, R. Abraham, M. Sandri, C. Reggiani, and S. Schiaffino Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle Hum. Mol. Genet., December 1, 2008; 17(23): 3686 - 3696. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Kollias and J. C. McDermott Transforming growth factor-{beta} and myostatin signaling in skeletal muscle J Appl Physiol, March 1, 2008; 104(3): 579 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Mendias, K. I. Bakhurin, and J. A. Faulkner Tendons of myostatin-deficient mice are small, brittle, and hypocellular PNAS, January 8, 2008; 105(1): 388 - 393. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |